Autism Spectrum Disorder Clinical Trials

Find Autism Spectrum Disorder Clinical Trials Near You

Characterization of (A)Typical Sensorimotor Pathways in Individuals With Autism

Status: Recruiting
Location: See location...
Intervention Type: Diagnostic test
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The goal of this interventional study is to understand whether sensorimotor skills could represent an endophenotype for autism, i.e. a specific class of biomarkers that bridges the gap between biological components of a condition and the behavioral/clinical dimensions. Motor and sensory differences are often observed in people with autism and may appear early in development or be shared among family members. The study will address three main questions: * What are the developmental effects of early differences in motor and sensory skills? * Are motor and sensory abilities influenced by family relationships? * Can studying motor and sensory differences in autism help researchers better understand the biological mechanisms underlying the condition? This study is structured in three topic-oriented work packages (WPs): WP1, a longitudinal assessment of sensorimotor skills as early predictors of later social characteristics in a mixed sample of infant siblings of autistic children (at elevated likelihood of autism) or with typical familial likelihood (no first-degree relatives with autism) (Q1); WP2, a cross-sectional investigation of sensorimotor abilities in autistic children and their parents as compared with typically developing children and their parents (Q2); and WP3, a dense-phenotyping approach to establish, within individuals, associations between traits across behavioral, neural, and molecular levels.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 1
Healthy Volunteers: t
View:

• children aged 2 to 12 years (both autistic and typically developing)

• Clinical diagnosis of Autism Spectrum Disorder based on clinical judgment according to DSM-5 criteria (for the autism group).

• being parents of the enrolled children (both autistic and typically developing)

• infants younger than 24 months of age with a first-degree family member with a clinical diagnosis of Autism Spectrum Disorder.

Locations
Other Locations
Italy
IRCCS E. Medea
RECRUITING
Bosisio Parini
Contact Information
Primary
Alessandro Crippa, PhD
alessandro.crippa@lanostrafamiglia.it
39 031877593
Time Frame
Start Date: 2024-05-21
Estimated Completion Date: 2026-12
Participants
Target number of participants: 300
Treatments
Experimental: Experimental: Clinical, neuropsychological, neurophysiological, and genetic evaluations
All children and their parents enrolled in the study will undergo an assessment of intellectual functioning, and a direct evaluation of motor skills using the Movement Assessment Battery for Children - Thirs Edition (MABC-3). Motor skills will also be assessed indirectly through either a parent or self-completed questionnaire. The motor profile of the participants will be further characterized using kinematic analysis of upper-limb movements during two experimental tasks.
Related Therapeutic Areas
Sponsors
Leads: IRCCS Eugenio Medea

This content was sourced from clinicaltrials.gov